Stephen Gordon - 01 Mar 2023 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role
Chief Financial Officer
Signature
By: /s/ Stephen Gordon
Issuer symbol
TMDX
Transactions as of
01 Mar 2023
Transactions value $
-$316,850
Form type
4
Filing time
02 Mar 2023, 16:00:42
Previous filing
22 Feb 2023
Next filing
02 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMDX Common Stock Options Exercise $80.7K +5K +26.61% $16.14 23.8K 01 Mar 2023 Direct F1
transaction TMDX Common Stock Sale -$398K -5K -21.02% $79.51 18.8K 01 Mar 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMDX Stock Option (Right to Buy) Options Exercise $0 -5K -24.12% $0.00 15.7K 01 Mar 2023 Common Stock 5K $16.14 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.
F2 Includes 13,075 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F3 The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 27, 2024.